Go back

UK ‘slipping behind’ as life sciences superpower

             

Pharmaceutical companies urge prime ministerial candidates to increase R&D investment to reverse negative trends

A trade association representing 120 UK pharmaceutical companies has urged Rishi Sunak and Liz Truss to make UK life sciences “central” to their agenda if they become the next UK prime minister.

In a letter to the Conservative Party leadership candidates dated 31 July, Richard Torbett, the chief executive of the Association of the British Pharmaceutical Industry, warned that there are “real signs that the UK is slipping behind our global competitors in the race to become a life sciences superpower”.

This article is only available to Research Professional News subscribers. If you are a subscriber you can read the article in full on researchprofessional.com

Pivot-RP users can log in and view the article via this link.